SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-13-000068
Filing Date
2013-07-22
Accepted
2013-07-22 08:41:07
Documents
3
Period of Report
2013-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligand-form8xkxlicenseagre.htm 8-K 20226
2 EXHIBIT-PRESS RELEASE pressrelease-azurelasofoxi.htm EX-99.1 13773
3 LIGAND IMAGE pressreleaseazu_image1.gif GRAPHIC 11576
  Complete submission text file 0000886163-13-000068.txt   51307
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 13978338
SIC: 2834 Pharmaceutical Preparations